Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02465931 · ClinicalTrials.gov registry record · NA
Decisional Capacity and Informed Consent in Fragile X Syndrome
A NA study, sponsored by RTI International.
- Completed
- Registry status
- NA
- Development phase
- 152
- Enrollment target
NCT02465931 is a NA study that has completed, run by RTI International. The registered enrollment target is 152 participants.
The verdict
NCT02465931, a NA study, has completed, sponsored by RTI International.
- COMPLETED
- Registry status
- NA
- Development phase
- 152 participants
- Enrollment target
Study Summary
The Decisional Capacity and Informed Consent in Fragile X Syndrome (FXS) project is for the Eunice Kennedy Shriver National Institute of Child Health \& Human Development, 1R01HD071987-01A1, and will provide the first comprehensive description of decisional capacity of individuals with FXS; identify individual, family, and experiential factors associated with variability in decisional capacity; determine the validity of caregiver and expert ratings; and develop evidence-based guidelines for categorizing decisional capacity of individuals with FXS. The researchers will develop a methodologically rigorous and conceptually grounded decision aid using digital technology to enhance participation of individuals with FXS in the consent process.
Interventions
- OTHER Paper and Pencil Informed Consent
- OTHER Digital Informed Consent Tool
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 152 participants |
| Start Date | 2016-03-14 |
| Est. Completion | 2017-03-21 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02465931
The ClinicalTrials.gov registry entry for NCT02465931 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 152 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is RTI International, which has 45 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Paper and Pencil Informed Consent is the first listed.
NCT02465931 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02465931 about?
NCT02465931 is a clinical study titled "Decisional Capacity and Informed Consent in Fragile X Syndrome". The Decisional Capacity and Informed Consent in Fragile X Syndrome (FXS) project is for the Eunice Kennedy Shriver National Institute of Child Health \& Human Development, 1R01HD071987-01A1, and will provide the first comprehensive description of decisional capacity of individuals with FXS; identify...
What is the current status of trial NCT02465931?
This trial is currently completed. It is a NA study. The enrollment target is 152 participants. The study started on 2016-03-14. Estimated completion is 2017-03-21.
What interventions are being tested in trial NCT02465931?
The interventions under investigation include: Paper and Pencil Informed Consent (OTHER), Digital Informed Consent Tool (OTHER).
Who is sponsoring clinical trial NCT02465931?
This trial is sponsored by RTI International, which has 45 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.